BiotechTube
Home/Purple Biotech/Mikael D. Törnqvist
MD

Mikael D. Törnqvist

Chief Scientific Officer

Purple Biotech

Therapeutic Areas

Oncology

Purple Biotech Pipeline

DrugIndicationPhase
CM24Non-Small Cell Lung CancerPhase 2
NT219Recurrent/Metastatic Head & Neck Squamous Cell CarcinomaPhase 1/2

Leadership Team at Purple Biotech

II
Isaac Israel
Chief Executive Officer
GE
Gil Efron
Chief Financial Officer
View full Purple Biotech profile